Bhagiradha Chemicals & Industries
BHAGCHEM NSE
Bhagiradha Chemicals & Industries
ChemicalsNSE: BHAGCHEM BSE: 531719 Pesticides & Agrochemicals
Key Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsMarket Cap
₹3,333 Cr
Volatility
Moderate
P/E Ratio
122.05
EBITDA
₹59.50 Cr
Return on Equity
2.6%
Debt to Equity
0.34
Book Value
₹53.85
EPS
₹1.76
52W High
₹316.9
52W Low
₹170.6
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
6- Stock is trading at 4.80 times its book value
- The company has delivered a poor sales growth of 11.0% over past five years.
- Promoter holding is low: 19.6%
- Company has a low return on equity of 3.14% over last 3 years.
- Dividend payout has been low at 10.2% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.92%
Growth Rate
Revenue Growth
19.68% higher than
3Y
Net Income Growth
30.94% higher than
3Y
Cash Flow Change
123% higher than
3Y
ROE
28.08% higher than
3Y
ROCE
0.46% higher than
3Y
EBITDA Margin (Avg.)
7.49% higher than
3Y
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 69d agoAI opinion · based on fundamentals
Risk high
Bhagiradha Chemicals & Industries Ltd is a small-cap agrochemical company with a market cap of ₹3,674 Cr trading at a PE of 201.8x. The company shows TTM sales growth of 22% but has delivered negative profit CAGR of -26% over 3 years, with ROE at just 3% over the last 3 years and promoter holding at a low 19.6%.
Bull Case 7
- TTM sales growth of 22% indicates a strong recent revenue recovery after muted 3-year sales CAGR of 2%
- TTM profit growth of 31% suggests margin expansion and earnings recovery in the most recent period
- Long-term stock price CAGR of 38% over 10 years and 39% over 5 years reflects significant wealth creation historically
- 3-year stock CAGR of 25% shows the market has rewarded the company despite weak fundamentals, indicating expectations of future improvement
- Operates in the agrochemicals space which benefits from India's large agricultural economy and government push for crop protection
- 5-year compounded sales growth of 11% demonstrates the company has been able to grow its topline over a medium-term horizon
- Market cap of ₹3,674 Cr places it in the small-to-mid cap space where re-rating potential exists if earnings sustain their TTM recovery trajectory
Bear Case 8
- PE ratio of 201.8x is extremely elevated, implying the stock is priced for significant future growth that has not yet materialized in sustained earnings
- 3-year ROE of just 3% indicates very poor capital efficiency and weak returns for shareholders
- 3-year compounded profit CAGR of -26% shows earnings have deteriorated significantly over the medium term
- Promoter holding is low at 19.6% and has declined by 3.92% over the last 3 years, raising governance and alignment concerns
- Price-to-book ratio of 5.24x is high relative to the 3% ROE, meaning investors are paying a steep premium for assets generating below-cost-of-capital returns
- Dividend payout of just 10.2% of profits over the last 3 years with a yield of only 0.05% offers minimal income to shareholders
- 5-year compounded profit CAGR of -4% confirms that earnings have been in structural decline even over a longer horizon
- 5-year sales growth of 11% is characterized as poor for a company in a growing agrochemical market, indicating market share or pricing challenges
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 69d ago Neutral 1
- Promoter holding steady at 19.60% Jun 23
Promoters of Bhagiradha Chemicals held 19.60% stake (2,54,10,000 shares) as on March 31, 2026, with no encumbrance reported on any shares.
TL;DR: Limited recent news flow for Bhagiradha Chemicals. The sole update confirms stable promoter holding at 19.60% with zero pledge, which signals no immediate governance concern. With no material positive or negative catalysts visible, the stock lacks a near-term directional trigger from newsflow alone.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 122 | 74 | 111 | 111 | 104 | 103 | 123 | 124 | 140 | 114 | 158 | 195 |
| Expenses | 93 | 109 | 66 | 97 | 99 | 94 | 94 | 117 | 115 | 125 | 100 | 139 | 164 |
| Operating Profit | 7 | 13 | 8 | 14 | 12 | 10 | 9 | 6 | 9 | 15 | 14 | 19 | 31 |
| OPM % | 7% | 11% | 11% | 13% | 11% | 9% | 9% | 5% | 7% | 11% | 12% | 12% | 16% |
| Other Income | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 1 | 1 | 0 | 1 | 1 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 4 | 3 | 7 | 6 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 8 | 8 |
| PBT | 3 | 9 | 5 | 11 | 10 | 8 | 6 | 2 | 2 | 8 | 6 | 5 | 18 |
| Tax % | 36% | 33% | 31% | 32% | 41% | 30% | 35% | 140% | -59% | 27% | 27% | 15% | 24% |
| Net Profit | 2 | 6 | 3 | 7 | 6 | 5 | 4 | -1 | 4 | 6 | 5 | 4 | 13 |
| EPS in Rs | 0.19 | 0.55 | 0.32 | 0.69 | 0.46 | 0.44 | 0.29 | -0.07 | 0.31 | 0.42 | 0.36 | 0.31 | 1.03 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 246 | 318 | 436 | 502 | 408 | 440 | 536 | 607 |
| Expenses | 229 | 271 | 367 | 425 | 365 | 404 | 479 | 528 |
| Operating Profit | 17 | 47 | 68 | 77 | 43 | 37 | 57 | 79 |
| OPM % | 7% | 15% | 16% | 15% | 11% | 8% | 11% | 13% |
| Other Income | 4 | 2 | 1 | 1 | 3 | 9 | 2 | 4 |
| Interest | 5 | 8 | 9 | 5 | 8 | 7 | 17 | 21 |
| Depreciation | 7 | 8 | 9 | 10 | 11 | 14 | 21 | 25 |
| PBT | 9 | 32 | 51 | 64 | 27 | 25 | 21 | 36 |
| Tax % | 27% | 27% | 30% | 29% | 32% | 45% | 14% | — |
| Net Profit | 7 | 23 | 36 | 45 | 18 | 14 | 18 | 28 |
| EPS in Rs | 0.63 | 2.27 | 3.48 | 4.34 | 1.75 | 1.07 | 1.4 | 2.12 |
| Div. Payout % | 0% | 0% | 7% | 9% | 6% | 14% | 11% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 10 | 10 | 13 | 13 |
| Reserves | 124 | 147 | 182 | 303 | 403 | 669 | 685 |
| Borrowings | 43 | 62 | 81 | 50 | 62 | 89 | 235 |
| Other Liabilities | 50 | 55 | 71 | 83 | 101 | 162 | 187 |
| Total Liabilities | 225 | 273 | 342 | 447 | 576 | 933 | 1,120 |
| Fixed Assets | 138 | 152 | 157 | 173 | 214 | 245 | 580 |
| CWIP | 4 | 2 | 5 | 28 | 68 | 289 | 96 |
| Investments | 0 | 0 | 0 | 0 | 38 | 0 | 0 |
| Other Assets | 83 | 119 | 181 | 246 | 256 | 399 | 445 |
| Total Assets | 225 | 273 | 342 | 447 | 576 | 933 | 1,120 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 48 | 4 | 7 | 14 | 34 | -53 | 12 |
| Investing | -39 | -21 | -17 | -60 | -116 | -201 | -160 |
| Financing | -9 | 15 | 12 | 46 | 88 | 272 | 136 |
| Net Cash Flow | 0 | -2 | 2 | 1 | 7 | 18 | -12 |
| Free Cash Flow | 9 | -17 | -10 | -46 | -45 | -302 | -148 |
| CFO/OP | 304 | 20 | 21 | 33 | 91 | -123 | 34 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 68 | 81 | 94 | 96 | 144 | 139 |
| Inventory Days | 137 | 97 | 91 | 108 | 168 | 173 | 161 |
| Days Payable | 59 | 89 | 73 | 69 | 98 | 125 | 152 |
| Cash Conversion Cycle | 95 | 76 | 99 | 132 | 166 | 193 | 148 |
| Working Capital Days | -12 | 21 | 32 | 90 | 94 | 124 | 117 |
| ROCE % | — | 20% | 25% | 22% | 8% | 5% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bhagiradha Chemicals & Industries insights
63 extracted metrics + investor summaries across FY11–FY27.
Documents
1
Clarification sought from Bhagiradha Chemicals & Industries Ltd
22 Jun - Exchange has sought clarification from Bhagiradha Chemicals & Industries Ltd on June 22, 2026, with reference to Movement in Volume. 22 Jun - Exchange has sought clarification from Bhagiradha Chemicals & Industries Ltd on June 22, 2026, with reference to Movement in Volume.
2
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter/Year Ended On March 31, 2026
6 May - Board to meet on May 19, 2026 to approve FY26 audited results, dividend, book closure and AGM details. 6 May - Board to meet on May 19, 2026 to approve FY26 audited results, dividend, book closure and AGM details.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
17 Apr - Company confirms it is not a Large Corporate; outstanding long-term borrowings were Rs. 34.04 crore. 17 Apr - Company confirms it is not a Large Corporate; outstanding long-term borrowings were Rs. 34.04 crore.
4
Clarification On Significant Movement In Price
10 Apr - Company clarified recent share price movement was market-driven, with no pending material announcement. 10 Apr - Company clarified recent share price movement was market-driven, with no pending material announcement.
5
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Apr - Newspaper Publication regarding opening of special window for transfer and dematerialization of physical securities and IEPFA Second 100 days campaign titled Saksham Niveshak 7 Apr - Newspaper Publication regarding opening of special window for transfer and dematerialization of physical securities and IEPFA Second 100 days campaign titled Saksham Niveshak
Frequently Asked Questions about Bhagiradha Chemicals & Industries
What does Bhagiradha Chemicals & Industries Ltd do?
Bhagiradha Chemicals & Industries is an Agro Chemical Company in India involved in the manufacturing of insecticides, fungicides, herbicides etc. It was Promoted by late Sri S. Koteswara Rao, a former scientist of Indian Institute of Chemical Technology, Hyderabad in the year 1993.[1][2]
Where is Bhagiradha Chemicals & Industries Ltd (BHAGCHEM) listed?
Bhagiradha Chemicals & Industries Ltd trades as BHAGCHEM on the NSE and under code 531719 on the BSE.
Which sector does Bhagiradha Chemicals & Industries Ltd belong to?
Bhagiradha Chemicals & Industries Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd has a market capitalisation of ₹3,333 Cr, which places it in the Small Cap band.
What is the PE ratio of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd trades at a PE ratio of 122.05, on earnings per share of ₹1.76, against a book value of ₹53.85 per share.
What is the 52-week high and low of Bhagiradha Chemicals & Industries Ltd?
Over the last 52 weeks Bhagiradha Chemicals & Industries Ltd has traded between ₹170.6 and ₹316.9.
Does Bhagiradha Chemicals & Industries Ltd pay dividends?
Bhagiradha Chemicals & Industries Ltd has a dividend yield of 0.06%.
What is the Return on Equity (ROE) of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd reported a return on equity of 2.60%. Its debt-to-equity ratio is 0.34.
Company Information
Bhagiradha Chemicals & Industries is an Agro Chemical Company in India involved in the manufacturing of insecticides, fungicides, herbicides etc. It was Promoted by late Sri S. Koteswara Rao, a former scientist of Indian Institute of Chemical Technology, Hyderabad in the year 1993.[1][2]
Website bhagirad.com
CEO Mr. Arvind Kumar Anegondi
Employees 546
Listed 2021-10-18
Face Value ₹ 1
Issued Size 12,96,69,080
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BHAGCHEM.md for Bhagiradha Chemicals & Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.